Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met Oct. 11.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Announcements
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. PDL Drug Appeals
a. Rinvoq-Dr. Jain/NeeleshNadkarni
b. Adbry
VII. New Drug Appeals
a. Glatiramer
VIII. Drug Class Review- Jen Phillips, PharmD clinical review (with discussion and vote)
a. HIV medications-Single Tablet Regimens
IX. New Drug Initial Review-Jen Phillips, PharmD clinical review (with discussion and vote)
a. Iqirvo
b. Winrevair
c. Zoryve
X. Public Comments (please see Pharmacy | HFS (illinois.gov) for Public Speaking guidelines and Registration forms)
XI. Old and New Business
XII. Future Agenda Preview -Sheri Dolan
• D&T Advisory Board Meeting Dates 2025
XIII. Provider Requested Reviews-Sheri Dolan
a. None for this meeting
XIV. Department Update-Jose Jimenez
XV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/dtadvisoryboardagenda10112024.pdf
Alerts Sign-up